Prognostic Value of Fibrinogen-to-Albumin Ratio and Neutrophil-to-Lymphocyte Ratio in Patients on Peritoneal Dialysis
Life · 09.11.2025 · 15 (11) · 1728
DOI: 10.3390/life15111728 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 09.11.2025. Verfasst von Selena Gajić und 15 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives: Chronic inflammation (CIn) is common among peritoneal dialysis (PD) patients and contributes to adverse outcomes. However, the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and fibrinogen-to-albumin ratio (FAR) in PD remains uncertain. Methodology: In this prospective cohort study, 65 PD patients were followed for 18 months. Baseline demographic, clinical and laboratory data were collected and inflammatory indices were calculated. The composite outcome was all-cause mortality or transfer to hemodialysis (HD). Logistic regression analyses were used to identify independent predictors of outcomes.
Results
Over the 18-month follow-up, 23 patients (35.4%) died and 13 (20.0%) transferred to HD. Patients with adverse outcomes had higher baseline FAR, C-reactive protein (CRP) and serum glucose (Glc) levels and lower triglycerides (TG). In multivariate analysis, higher FAR (OR 5.28, 95% CI 1.16–24.12), CRP (OR 1.28, 95% CI 1.02–1.62) and PTH (OR 1.01, 95% CI 1.00–1.01) were independently associated with adverse outcomes, while NLR showed marginal significance. In the mortality-only model, FAR (OR 3.99, 95% CI 1.17–13.61) and PTH remained significant predictors.
Conclusions
FAR demonstrated a significant prognostic association with mortality and composite adverse outcomes in PD patients, whereas NLR had limited predictive value. Albumin-based inflammatory indices such as FAR may complement established markers for risk stratification. Larger multicenter studies are warranted to validate these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic of Nephrology, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia.
- Faculty of Medicine, University of Belgrade, Dr Subotića Starijeg 8, 11000 Belgrade, Serbia.
- Center for Medical Biochemistry, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
- Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, Serbia.
- Clinic for Emergency Surgery, Emergency Center, University Clinical Center of Serbia, Pasterova 2, 11000 Belgrade, Serbia.
ORCID-Profile: Selena Gajić, Ana Bontić, Aleksandar Sič, Vidna Karadžić-Ristanović, Milorad Stojadinović, Kristina Filić, Sanja Stanković, Nikola Trnić, Svetlana Jovičić-Pavlović, Aleksandra Kezić, Marko Baralić
Zitieren
APA
Gajić, S., Bontić, A., Sič, A., Karadžić-Ristanović, V., Stojadinović, M., Filić, K., Pavlović, J., Gavrilović, J., Petrović, K., Stanković, S., Trnić, N., Simović, F., Popović, P., Jovičić-Pavlović, S., Kezić, A., & Baralić, M. (2025). Prognostic Value of Fibrinogen-to-Albumin Ratio and Neutrophil-to-Lymphocyte Ratio in Patients on Peritoneal Dialysis. Life, 15(11), 1728. https://doi.org/10.3390/life15111728
Vancouver
Gajić S, Bontić A, Sič A, Karadžić-Ristanović V, Stojadinović M, Filić K, et al. Prognostic Value of Fibrinogen-to-Albumin Ratio and Neutrophil-to-Lymphocyte Ratio in Patients on Peritoneal Dialysis. Life. 2025;15(11):1728. doi:10.3390/life15111728
BibTeX
@article{Gaji2025,
author = {Gajić, Selena and Bontić, Ana and Sič, Aleksandar and Karadžić-Ristanović, Vidna and Stojadinović, Milorad and Filić, Kristina and Pavlović, Jelena and Gavrilović, Jovana and Petrović, Kristina and Stanković, Sanja and Trnić, Nikola and Simović, Filip and Popović, Pavle and Jovičić-Pavlović, Svetlana and Kezić, Aleksandra and Baralić, Marko},
title = {Prognostic Value of Fibrinogen-to-Albumin Ratio and Neutrophil-to-Lymphocyte Ratio in Patients on Peritoneal Dialysis},
journal = {Life},
year = {2025},
volume = {15},
number = {11},
pages = {1728},
doi = {10.3390/life15111728}
}
EUVIMED